Subscribe To
TEVA / Teva Pharmaceutical Industries Ltd. (TEVA) CEO Kåre Schultz on Q4 2021 Results - Earnings Call Transcript
Content Topics
Brookfield
Asset
Management
Reinsurance
Partners
Ltd
Bamr
Pharmaceutical
Industries
teva
Schultz
Results
Earnings
Transcript
Stock
TEVA
TEVA News
By Reuters
October 10, 2023
Drugmaker Teva does not see big impact on business from Israel-Hamas war
Israel's war with Hamas is not expected to have much impact on Teva Pharmaceutical Industries' business performance, the company said on Tuesday. more_horizontal
By See It Market
September 12, 2023
TEVA: A Pharmaceutical Stock to Watch Right Now
Every week, I am invited on Business First AM with Angela Miles to discuss the market and give a stock pick. This week, I covered TEVA, a stock I have more_horizontal
By Seeking Alpha
September 11, 2023
Teva Pharmaceutical Industries Limited (TEVA) Morgan Stanley 21st Annual Global Healthcare Conference 2023 (Transcript)
Teva Pharmaceutical Industries Limited (NYSE:TEVA ) Morgan Stanley 21st Annual Global Healthcare Conference 2023 Call September 11, 2023 8:40 AM ET Co more_horizontal
By Seeking Alpha
August 26, 2023
The Mighty Teva Pharmaceutical: Unveiling A Bullish Scenario You Must Consider
On August 2, Teva Pharmaceutical published its financial report for the second quarter of 2023, which showed an improvement in its financial position. more_horizontal
By Zacks Investment Research
August 23, 2023
TEVA to Pay $225 Million to Settle Price-Fixing Charges (Revised)
TEVA agrees to pay a fine of $225 million over five years per a DPA. Out of this amount, $22.5 million will be due each year from 2024 through 2027 an more_horizontal
By Zacks Investment Research
August 22, 2023
TEVA to Pay $250 Million to Settle Price-Fixing Charges
TEVA agrees to pay a fine of $225 million over five years per a DPA. Out of this amount, $22.5 million will be due each year from 2024 through 2027 an more_horizontal
By Proactive Investors
August 22, 2023
Teva Pharma lands US$225 million fine for price-fixing
Generic drug maker Teva Pharmaceuticals is to pay US $225 million in fines after admitting price-fixing on a range of drugs in the US. Teva and anothe more_horizontal
By CNN Business
August 21, 2023
Teva to pay $225 million fine and divest cholesterol drug to settle price-fixing charges
Teva Pharmaceuticals agreed to pay more than $200 million in fines and divest a key generic drug treating cholestoral to settle price-fixing charges f more_horizontal